Melissa Reuter
Scientific Director, Global Diagnostic Lead Johnson & Johnson
As Director, Precision Medicine Diagnostics at J&J, contributes to implementing strategies that integrate precision medicine across heme oncology therapeutic development programs. Focuses on advancing companion diagnostics and enabling data-driven decision-making to improve patient outcomes. Expertise spans portfolio planning, research and development, and cross-functional collaboration to align business goals with innovative medical solutions.
With extensive experience in the life sciences and pharmaceutical industries, brings a mission-driven approach to fostering innovation and addressing unmet medical needs. Known for supporting organizational success through collaboration, harmonizing complex processes, and promoting research excellence within precision medicine.
Seminars
- Evaluating the clinical and analytical validation required for MRD to serve as a reliable surrogate endpoint across tumor types
- Aligning trial design, assay sensitivity, and timepoint selection to generate robust, regulator-ready evidence
- Exploring how MRD-driven endpoints could accelerate development timelines and inform earlier treatment decisions
